Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Intersect ENT (XENT) stocks in Canada
Learn how to easily invest in Intersect ENT stocks.
Intersect ENT is a medical devices business based in the US. Intersect ENT stocks (XENT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $19.33 – a decrease of 0.29% over the previous week. Intersect ENT employs 406 staff and has a trailing 12-month revenue of around $104.3 million.
How to buy shares in Intersect ENT
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – XENT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Intersect ENT?
- Has coronavirus impacted Intersect ENT shares?
- Intersect ENT shares summary
- Compare share dealing platforms
- Is Intersect ENT stock a buy or sell?
- Intersect ENT performance over time
- Intersect ENT's financials
- How volatile are Intersect ENT shares?
- Does Intersect ENT pay a dividend?
- Have Intersect ENT shares ever split?
- Other common questions
Intersect ENT stock price (NASDAQ:XENT)Use our graph to track the performance of XENT stocks over time.
Intersect ENT shares at a glance
|Latest market close||$27.12|
|52-week range||$15.92 - $28.17|
|50-day moving average||$27.14|
|200-day moving average||$23.87|
|Wall St. target price||$28.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.68|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Intersect ENT stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Intersect ENT price performance over time
|1 week (2022-01-16)||N/A|
|1 month (2021-12-27)||-0.77%|
|3 months (2021-10-27)||1.19%|
|6 months (2021-07-27)||25.85%|
|1 year (2021-01-27)||16.54%|
|2 years (2020-01-24)||9.40%|
|3 years (2019-01-25)||29|
|5 years (2017-01-26)||109.42%|
Intersect ENT financials
|Revenue TTM||$104.3 million|
|Gross profit TTM||$57.1 million|
|Return on assets TTM||-17.82%|
|Return on equity TTM||-181.73%|
|Market capitalisation||$910.2 million|
TTM: trailing 12 months
Intersect ENT share dividends
We're not expecting Intersect ENT to pay a dividend over the next 12 months.
Have Intersect ENT's shares ever split?
Intersect ENT's shares were split on a 1:4 basis on 10 July 2014. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Intersect ENT shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Intersect ENT shares which in turn could have impacted Intersect ENT's share price.
Intersect ENT share price volatility
Over the last 12 months, Intersect ENT's shares have ranged in value from as little as $15.92 up to $28.17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intersect ENT's is 1.5555. This would suggest that Intersect ENT's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Intersect ENT overview
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL and PROPEL Mini, which are steroid releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009.
Stocks similar to Intersect ENT
Intersect ENT in the news
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
Intersect ENT: Real-world Data Support Use Of PROPEL In Patients Undergoing Endoscopic Sinus Surgery
Earnings playbook: A complete guide to this week's reports, including the first of tech
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.